Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Vital Measurement

Inmedix’s Andrew J Holman stresses that medical-grade heart rate variability diagnostic technology will only be able to provide patients with better outcomes if companies look past financial matters.

Andrew J Holman at Inmedix (July 2017)

Keywords: diagnostic technology, medical-grade heart rate variability, stress, patient outcomes, finance

    View full article    |    Back to Bioprocessing section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |